Return to Faculty List


Douglas L. Jennings

Associate Professor, Pharmacy Practice

Pharm.D., Wayne State University, Detroit, MI


Dr. Jennings is an Associate Professor of Pharmacy at Long Island University, and he currently practices as the Clinical Pharmacist in Heart Transplant and Mechanical Circulatory Support at NewYork Presbyterian Columbia University Medical Center. He is an active researcher in his field, and he has published over 120 peer-reviewed abstracts and manuscripts, primarily focusing on the pharmacotherapy of patients under mechanical circulatory support. As a recognized expert in this area, he has been invited to speak at numerous national and international venues, including meetings in France, Saudia Arabia, India. Also, he was recently invited to co-author the 2020 update to the International Society of Heart and Lung Transplantion Guidelines for the Care of Heart Transplant Recipients. Finally, Dr. Jennings has been active in professional organizations throughout his career. He currently sits on Advanced Heart Failure and Transplant Leadership Council for the American College of Cardiology and the Programming Committee for the 2019 Annual Meeting for the Heart Failure Society of America. He is a fellow of the American College of Clinical Pharmacy, the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America.


Cardiology, heart transplant, mechanical circulatory support


Breslin NT, Salerno DM, Topkara VK, Latif F, Restaino S, Takeda K, Takayama H, Farr M, Colombo PC, Jennings DL. Prior Amiodarone Exposure Reduces Tacrolimus Dosing Requirements in Heart Transplant Recipients. Prog Transplant 2019 Mar doi: 10.1177/1526924819835840.

Jennings DL, Lange N, Shullo M, Baker WL. Mammalian Target of Rapamycin Inhibitors and Survival in Heart Transplant Recipients: Miracle or Mirage? J Am Coll

Cardiol 2018;71:2859-60.

Jennings DL. Increase in short-term of rejection in heart transplant patients receiving granulocyte colony-stimulating factor. J Heart Lung Transplant 2018;37:1475.

Jennings DL, Lange N, Shullo M, Latif F, Restaino S, Topkara VK, Takeda K, Takayama H, Naka Y, Farr M, Colombo P, Baker WL. Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: A meta-analysis. Int J Cardiol 2018;265:71-76.

Martinez BK, Yik B, Tran R, Ilham S, Coleman CI, Jennings DL, Baker WL. Meta-Analysis of Time in Therapeutic Range in Continuous-Flow Left Ventricular Assist Device Patients Receiving Warfarin. Artif Organs 2018;42:700–704.

Lee CL, Colombo PC, Eisenberger A, Diuguid D, Jennings DL, Han J, Salna MP, Takeda K,   Kurlansky PA, Yuzefpolskaya M, Garan AR, Naka Y, Takayama H. Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia. Ann Thorac Surg 2018;105:122-128.

Sieg A, Moretz JD, Horn E, Jennings DL. Pharmacotherapeutic Management of       Gastrointestinal Bleeding in Patients with Continuous-Flow Left-Ventricular Assist Devices.    Pharmacotherapy 2017;37:1432–1448.

Wright M, Takeda K, Mauro C, Jennings D, Kurlansky P, Han J, Truby L, Stein S, Topkara V, Garan AR, Yuzefpolskaya M, Colombo P, Naka Y, Farr M, Takayama H.  Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation.  J Heart Lung Transplant 2017;36:1226–1233.

Sabato LA, Salerno DM, Moretz JD, Jennings DL.  Inhaled pulmonary vasodilator therapy for management of right-ventricular dysfunction after left ventricular assist device placement and cardiac transplantation.  Pharmacotherapy 2017 37:944-955.

Jennings DL, Baker WL. Pre-cardiac transplant amiodarone use is not associated with postoperative mortality: An updated meta-analysis. Int J Cardiol 2017; 236:345-347.

Kuyumjian YM, Leverock J, Miyares MA, Bednar B, Chaparro S, Panos A,  Baker WL, Jennings DL. A multidisciplinary team-based process improves anticoagulation quality in patients with continuous-flow left-ventricular assist devices. Int J Cardiol 2016;218:118-119.

Jennings DL, Horn ET, Lyster H, Panos AL, Teuteberg JJ, Lehmkuhl HB, Perez A, Shullo MA.   Assessing anticoagulation practice patterns in patients on durable mechanical circulatory support devices: An international survey.  ASAIO J 2016;62:28-32.

Ton KV, Eisenberger A, Jennings DL, Colombo PC, Topkara VK.  Relationship of hemolysis with discordance in paired activated partial thromboplastin time and anti-factor Xa measurements in continuous-flow left ventricular assist device patients.  J Heart Lung Transplant 2016;35:1365-67.

Jennings DL, Weeks P. Thrombosis in continuous-flow left-ventricular assist devices: Pathophysiology, prevention and pharmacologic management. Pharmacotherapy 2015;35:79–98.

Jennings DL, Wagner JL, Nemerovski CW, Kalus JS, Morgan JA, Lanfear DE. Epidemiology and Outcomes Associated With Anemia During Long-Term Continuous-Flow Left Ventricular Assist Device Support.  J Card Fail 2014;20:387-391.

Jennings DL, Jacob M, Chopra A, Nemerovski C, Morgan JA, Lanfear DE.  Safety of anticoagulation reversal in patients supported with continuous-flow left-ventricular assist devices.  ASAIO J 2014;60:381-384.

Jennings DL, Makowski C, Chambers R, Lanfear DE.  Dosing of vancomycin in patients with continuous-flow left ventricular assist devices: A clinical pharmacokinetic analysis.  Int J Artif Organs 2014;37:270-4.

Jennings DL, Chopra A, Chambers R, Morgan JA.  Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left-ventricular assist devices.  Artificial Organs 2014;38:875-879.

Jennings DL*, Nemerovski CW, Kalus JK.  Effective anticoagulation for a percutaneous ventricular assist device using a heparin-based purge solution.  Ann Pharmacother 2013;47:1364–1367.

Lectures and Presentations

“Time in Therapeutic Range: Is There an Optimal Way to Manage INR?” International Society of Heart and Lung Transplantation Annual Meeting, Orlando, FL. April 2019.

“Perfecting Your Poster Presentations.” ACCP Annual Meeting, Seattle, WA. October 2018.

“Pharmacotherapy Considerations in Heart Failure Patients at the End of Life.” Heart Failure Society of America Annual Meeting, Nashville, TN. September 2018.

”Cardiotoxicity in Cancer: The Frontier Beyond Anthracyclines.” International Society of Heart and Lung Transplantation Annual Meeting, Nice, France. April 2018.

“An On Going Challenge : How to Improve Safe Management of Anticoagulation During Pregnancy.” American College of Cardiology Annual Scientific Session and Expo, Orlando, FL. March 2018.

“Ramifications of Antibiotic Prophylaxis Guidelines for Endocarditis Prophylaxis.” American College of Cardiology Annual Scientific Session and Expo, Orlando, FL. March 2018.

“Heart Transplant and Mechanical Circulatory Support.” Updates in Therapeutics® 2018: Cardiology Pharmacy Preparatory Review Course. ACCP Meeting in Jacksonville, FL. February 2018.

“Is Cangrelor the New CHAMPION for Antiplatelet Therapy during Percutaneous Coronary Intervention?” ASHP Midyear Clinical Meeting, Las Vegas, NV. December 2016.

“Cardiogenic Shock and Mechanical Circulatory Support for Advanced Heart Failure.” Clinical Reasoning Series at the ACCP Annual Meeting, Fort Lauderdale, FL. October 2016.

“Pre-operative Genetic Screening for Coagulation Abnormalities and Impact on Post-operative Management.” International Society of Heart and Lung Transplantation Annual Meeting, Washington, DC. April 2016.

“Diuretic Actions, Thresholds, Combinations, and Myths.” American College of Cardiology Annual Scientific Session and Expo, Chicago, IL. March 2016.

“The Beta Adrenergic Receptor Post-MI: Beta-Blocker Use Should Stop.” Pharmacotherapy Session II; American College of Cardiology Annual Scientific Session and Expo, San Diego, CA. March 2015.

“Optimizing Anticoagulation in Patients with Durable Mechanical Circulatory Support Devices.” ASHP Midyear Clinical Meeting, Anaheim, CA. December 2014.


Professional Affiliations

Fellow, American College of Clinical Pharmacy
Fellow, American College of Cardiology
Fellow, American Heart Association
Fellow, Heart Failure Society of America